探讨可溶性B7-H3 （sB7-H3）作为生物标志物在预测晚期癌症患者接受免疫检查点抑制剂（ICIs）治疗的临床获益和/或免疫相关不良事件（irAEs）发生中的作用

{"title":"探讨可溶性B7-H3 （sB7-H3）作为生物标志物在预测晚期癌症患者接受免疫检查点抑制剂（ICIs）治疗的临床获益和/或免疫相关不良事件（irAEs）发生中的作用","authors":"L. Liguori , G. Polcaro , V. Manzo , V. Pagliara , C. Ferrone , G. Cattaneo , E. Debellis , M. Cascella , A. Filippelli , V. Conti , S. Pepe , F. Sabbatino","doi":"10.1016/j.iotech.2024.100918","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73352,"journal":{"name":"Immuno-oncology technology","volume":"24 ","pages":"Article 100918"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"36P Exploring the role of soluble B7-H3 (sB7-H3) as a biomarker to predict the clinical benefit and/or the occurrence of immune related adverse events (irAEs) in advanced cancer patients treated with immune checkpoint inhibitors (ICIs)\",\"authors\":\"L. Liguori , G. Polcaro , V. Manzo , V. Pagliara , C. Ferrone , G. Cattaneo , E. Debellis , M. Cascella , A. Filippelli , V. Conti , S. Pepe , F. Sabbatino\",\"doi\":\"10.1016/j.iotech.2024.100918\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73352,\"journal\":{\"name\":\"Immuno-oncology technology\",\"volume\":\"24 \",\"pages\":\"Article 100918\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-oncology technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590018824002156\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-oncology technology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590018824002156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}